Radionuclide Myocardial Perfusion Imaging for the Evaluation of Patients With Known or Suspected Coronary Artery Disease in the Era of Multimodality Cardiovascular Imaging

Progress in Cardiovascular Diseases

Volumn 57, Issue 6, 2015, Pages 644-653

  Taqueti, Viviany R ^a   Di Carli, Marcelo F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Coronary flow reserve; Ischemic heart disease; Multimodality cardiovascular imaging; Positron emission tomography; Radionuclide myocardial perfusion imaging

Indexed keywords

RADIOISOTOPE;

ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; HEART MUSCLE BLOOD FLOW; HUMAN; MYOCARDIAL PERFUSION IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; CORONARY BLOOD VESSEL; FRACTIONAL FLOW RESERVE; MULTIMODAL IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING;

CORONARY ARTERY DISEASE; CORONARY VESSELS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MULTIMODAL IMAGING; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84930036666     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.03.004     Document Type: Article

References (45)

1. Beller G.A., Zaret B.L. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2000, 101:1465-1478.
2. Collins F.S., Varmus H. A new initiative on precision medicine. N Engl J Med 2015, 372:793-795.
3. Shaw L.J., Marwick T.H., Zoghbi W.A., et al. Why all the focus on cardiac imaging?. J Am Coll Cardiol Img 2010, 3:789-794.
4. Pennell D.J., Sechtem U.P., Higgins C.B., et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. J Cardiovasc Magn Reson 2004, 6:727-765.
5. Wolk M.J., Bailey S.R., Doherty J.U., et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation appropriate use criteria task force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014, 63:380-406.
6. Vesely M.R., Dilsizian V. Nuclear cardiac stress testing in the era of molecular medicine. J Nucl Med 2008, 49:399-413.
7. Patterson R.E., Horowitz S.F., Eisner R.L. Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994, 24:286-310.
8. Miller T.D., Hodge D.O., Christian T.F., Milavetz J.J., Bailey K.R., Gibbons R.J. Effects of adjustment for referral bias on the sensitivity and specificity of single photon emission computed tomography for the diagnosis of coronary artery disease. Am J Med 2002, 112:290-297.
9. Schuijf J.D., Poldermans D., Shaw L.J., et al. Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2006, 33:93-104.
10. Klocke F.J., Baird M.G., Lorell B.H., et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003, 108:1404-1418.
11. Di Carli M.F., Dorbala S., Meserve J., El Fakhri G., Sitek A., Moore S.C. Clinical myocardial perfusion PET/CT. J Nucl Med 2007, 48:783-793.
12. Parker M.W., Iskandar A., Limone B., et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging 2012, 5:700-707.
13. Mc Ardle B.A., Dowsley T.F., deKemp R.A., Wells G.A., Beanlands R.S. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol 2012, 60:1828-1837.
14. Dorbala S., Di Carli M.F. Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med 2014, 44:344-357.
15. Nesto R.W., Kowalchuk G.J. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987, 59:23C-30C.
16. Schinkel A.F., Bax J.J., Geleijnse M.L., et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?. Eur Heart J 2003, 24:789-800.
17. Gebker R., Jahnke C., Manka R., et al. Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease. Circ Cardiovasc Imaging 2008, 1:122-130.
18. Min J.K., Shaw L.J. Noninvasive diagnostic and prognostic assessment of individuals with suspected coronary artery disease: coronary computed tomographic angiography perspective. Circ Cardiovasc Imaging 2008, 1:270-281. [discussion 281].
19. Budoff M.J., Dowe D., Jollis J.G., et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter accuracy (assessment by coronary computed tomographic angiography of individuals undergoing invasive coronary angiography) trial. J Am Coll Cardiol 2008, 52:1724-1732.
20. Di Carli M.F., Dorbala S., Curillova Z., et al. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol 2007, 14:799-809.
21. Schuijf J.D., Wijns W., Jukema J.W., et al. Relationship between noninvasive coronary angiography with multi-slice computed tomography and myocardial perfusion imaging. J Am Coll Cardiol 2006, 48:2508-2514.
22. Iskandrian A.S., Chae S.C., Heo J., Stanberry C.D., Wasserleben V., Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993, 22:665-670.
23. Hachamovitch R., Berman D.S., Shaw L.J., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998, 97:535-543.
24. Hachamovitch R., Berman D.S., Kiat H., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996, 93:905-914.
25. Shaw L.J., Iskandrian A.E. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004, 11:171-185.
26. Sharir T., Germano G., Kang X., et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001, 42:831-837.
27. Gould K.L. Does coronary flow trump coronary anatomy?. JACC Cardiovasc Imaging 2009, 2:1009-1023.
28. El Fakhri G., Kardan A., Sitek A., et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)rb PET: comparison with (13)n-ammonia PET. J Nucl Med 2009, 50:1062-1071.
29. El Fakhri G., Sitek A., Guerin B., Kijewski M.F., Di Carli M.F., Moore S.C. Quantitative dynamic cardiac 82rb PET using generalized factor and compartment analyses. J Nucl Med 2005, 46:1264-1271.
30. Murthy V.L., Naya M., Foster C.R., et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011, 124:2215-2224.
31. Ziadi M.C., Dekemp R.A., Williams K.A., et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011, 58:740-748.
32. Fukushima K., Javadi M.S., Higuchi T., et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82rb PET perfusion imaging. J Nucl Med 2011, 52:726-732.
33. Herzog B.A., Husmann L., Valenta I., et al. Long-term prognostic value of 13n-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009, 54:150-156.
34. Naya M., Murthy V.L., Taqueti V.R., et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med 2014, 55:248-255.
35. Taqueti V.R., Hachamovitch R., Murthy V.L., et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015, 131:19-27.
36. Nahser P.J., Brown R.E., Oskarsson H., Winniford M.D., Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995, 91:635-640.
37. Murthy V.L., Naya M., Foster C.R., et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012, 126:1858-1868.
38. Taqueti V.R., Everett B.M., Murthy V.L., et al. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 2015, 131:528-535.
39. Bittencourt M.S., Hulten E., Ghoshhajra B., et al. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging 2014, 7:282-291.
40. Hachamovitch R., Nutter B., Hlatky M.A., et al. Patient management after noninvasive cardiac imaging results from SPARC (study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012, 59:462-474.
41. Gowd B.M., Heller G.V., Parker M.W. Stress-only SPECT myocardial perfusion imaging: a review. J Nucl Cardiol 2014, 21:1200-1212.
42. Berman D.S., Maddahi J., Tamarappoo B.K., et al. Phase ii safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol 2013, 61:469-477.
43. Yu M., Guaraldi M.T., Mistry M., et al. BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007, 14:789-798.
44. Rozanski A., Gransar H., Hayes S.W., et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol 2013, 61:1054-1065.
45. Iskandrian A.E., Hage F.G. Declining frequency of ischemia detection using stress myocardial perfusion imaging. J Am Coll Cardiol 2013, 61:1066-1068.